Brief: Amneal Pharma Expects To Meet Or Exceed Its 2025 Full-Year Financial Guidance
13/01/2026 12:48
Jan 13 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O: AMNEAL PHARMA: EXPECTS TO MEET OR EXCEED ITS 2025 FULL-YEAR FINANCIAL GUIDANCE FY2025 EARNINGS PER SHARE VIEW $0.80, REVENUE VIEW $3.01 BILLION -- LSEG IBES DATA Further company coverage: AMRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amneal Pharmaceuticals
See all newsUS FDA is working with manufacturers to boost estrogen patch supply amid access concerns (updated)
U.S. RESEARCH ROUNDUP- Intuit, MongoDB, Zscaler
U.S. STOCKS ON THE MOVE-Mastercard, Yum, Equinix
Amneal Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Mastercard, Starbucks, Meta